Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.bahiana.edu.br:8443/jspui/handle/bahiana/2982
Título : Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance
Otros títulos : Journal of Cardiothoracic Surgery
Autor : Melo, Rodrigo Morel Vieira de
Oikawa, Fernando Teiichi Costa
Hueb, Whady
Nomura, Cesar Higa
Hueb, Alexandre Ciappina
Villa, Alexandre Volney
Costa, Leandro Menezes Alves da
Rezende, Paulo Cury
Segre, Carlos Alexandre Wainrober
Garzillo, Cibele Larrosa
Lima, Eduardo Gomes
Ramires, Jose Antonio Franchini
Kalil Filho, Roberto
Palabras clave : Myocardial infarction; Biomarkers; Coronary bypass surgery; Periprocedural; Troponin
Fecha de publicación : 2017
Resumen : Myocardial necrosis biomarkers are frequently elevated after cardiac revascularization procedures. However, the diagnosis of acute myocardial infarction (MI) after a revascularization procedure is still a controversial issue. This inability to diagnose MI makes it more difficult to establish a specific therapeutic strategy. With the appearance of high-sensitivity troponins, a myriad of false-positive diagnoses for myocardial infarction have emerged. In 2000 and 2007 in an attempt to standardize the criteria for diagnosing MI, the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation formed a joint task force to address this issue, but the task force was unable to make a satisfactory decision. Therefore, the problem still remained. To reduce diagnostic mistakes, in 2012, this same group arbitrarily raised the cutoff point to 10 times the 99th percentile, but with no solid scientific basis for doing so [1]. Troponin (cTnI) and the creatine kinase isoform (CK-MB) do not reflect, alone, the occurrence of MI related to occlusion of the graft or native artery or varying degrees of myocardial injury. Release of myocardial necrosis markers may be related to incomplete myocardial protection; reperfusion injury; a systemic inflammatory state, including inevitable postsurgical trauma; the handling of intramyocardial vessels; and cardiac defibrillator use [2, 3]. Cardiac troponin may also be increased when nonsurgical damage is present, such as sepsis and thromboembolic phenomena [1]. cTnIs have also been found elevated in athletes after marathons [4]. This makes the identification of small areas of injury very difficult to assess in clinical practice [5]. Parallel to the increased sensitivity of troponin assays, imaging methods have achieved better accuracy for exclusion of the diagnosis of myocardial infarction. Thus, due to the limitations on the interpretation of biomarkers after coronary artery bypass grafting (CABG) and the difficulty of excluding MI, cardiac magnetic resonance imaging (CMR) has enabled a more detailed evaluation of the myocardium. Therefore, in this study, we aimed to examine the release of biomarkers after CABG in patients with no evidence of late enhancement on CMR.
URI : http://www7.bahiana.edu.br//jspui/handle/bahiana/2982
ISSN : 1749-8090
Aparece en las colecciones: Artigos Completos Publicados em Periódicos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
ARTIGO- RODRIGO MELO-2017.pdf636 kBAdobe PDFVisualizar/Abrir

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.